Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. MGC Pharmaceuticals Limited
  6. Company
    MXC   AU000000MXC6

MGC PHARMACEUTICALS LIMITED

(MXC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo MGC Pharmaceuticals Limited
MGC Pharmaceuticals Limited is an Australia-based biopharma company. The Company is primarily focused on producing standardized, phytocannabinoid and plant-derived medicines. The CompanyÔÇÖs Nature to Medicine strategy comprises the entire supply chain, from botanical research, to develop new strains of Cannabis Sativa, preclinical and clinical research, product manufacturing, distribution, as well as the development of drug delivery systems. The Group has also completed a Phase II double-blind, randomized, placebo controlled clinical trial in Israel and India, to evaluate the safety and efficacy of a natural anti-inflammatory based formulation ArtemiC on patients diagnosed with Corona Virus Disease 2019 (COVID-19).
Sales per Business
2021
Cannabinoids2.7392%
Consulting Services0.248%
AUD in Million
Sales per region
2021
Australia1.6555.8%
Slovenia1.0936.8%
Israel0.268.6%
AUD in Million
Managers
Name Title Age Since
Roby Reuven Zomer Chief Executive Officer, Director & MD 41 -
Amir Polak Chief Technology Officer - 2020
Stephen B. Parker, Dr. Senior Independent Director 63 2021
Evan Hayes Independent Non-Executive Director - 2020
Rachel Jelleff Kerr Joint Secretary - 2020
Nadine Barry Joint Secretary - 2021
David Lim Joint Secretary - 2021
Nicole Savage Godresse Global Chief Sales Officer - 2021
Ron Lipsky Vice President-Business Development - -
Members of the board
Name Title Age Since
Brett Anthony Mitchell Executive Chairman 50 -
Nativ Segev Director - 2017
Roby Reuven Zomer Chief Executive Officer, Director & MD 41 -
Ross Walker Non-Executive Director - 2016
Stephen B. Parker, Dr. Senior Independent Director 63 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,319,502,595 2,176,984,994 93.9% 0 0.0% 93.9%
Shareholders
NameEquities%
Computershare Limited 861,191,552 31.9%
Chelverton Asset Management Ltd. 81,250,000 3.01%
Nativ Segev 53,000,001 1.96%
George Bishay 36,822,890 1.36%
Mercer Street Global Opportunity Fund LLC 34,300,000 1.27%
Roby Reuven Zomer 33,000,001 1.22%
Miton Asset Management Ltd. 28,635,618 1.06%
Brett Anthony Mitchell 25,574,586 0.95%
Cannvalate Pty Ltd. 15,151,515 0.56%
Chetcuti Holdings Pty Ltd. 12,000,000 0.44%
Holdings
NameEquities%Valuation
CHESSER RESOURCES LTD 5,714,286 24.0% 519,314 USD
Company contact information
MGC Pharmaceuticals Ltd.
1008 Hay Street
Level 7
Perth, Western Australia (WA) 6000

Phone : +61.8.9389.2000
Fax : +61.8.9389.2099
Web : http://www.mgcpharma.com.au
Brand Portfolio
In partnership withAllbrands.markets
More brands of MGC Pharmaceuticals Limited